XML 43 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Shared-Based Compensation
9 Months Ended
Sep. 30, 2012
Shared-Based Compensation [Abstract]  
Shared-Based Compensation
Note 11. Shared-Based Compensation

During the three and nine month periods ended September 30, 2012 and 2011, approximately $510 and $1,394 in 2012 and $353 and $469 in 2011, respectively, of compensation expense was recognized in selling, general and administrative expense for all share-based awards. During the nine month periods ended September 30, 2012 and 2011, there were 78 share awards and 285 option awards and 75 share awards and 216 option awards, respectively, granted to non-executive directors, officers and certain other key employees.

The restricted shares granted during the nine month periods ended September 30, 2012 and 2011, vest pro-rata over three years. During the nine month periods ended September 30, 2012 and 2011, we incurred $608 and $199, respectively, in expense related to restricted stock. The fair value of the shares issued was determined by using the grant date closing price of our common stock.

We incurred $786 and $270 of stock option expense in the nine month periods ended September 30, 2012 and 2011, respectively. The fair value of our options cannot be determined by market value, as our options are not traded in an open market. Accordingly, the Black Scholes financial pricing model is utilized to estimate the fair value.

The following table provides a reconciliation of option activity for the nine month period ended September 30, 2012:

 

                                 

Options

  Shares (000)     Weighted-
Average
Exercise
Price
    Weighted-
Average
Remaining
Contractual
Term
    Aggregate
Intrinsic
Value ($000)
 

Outstanding at January 1, 2012

    1,141     $ 10.12                  

Granted

    285     $ 8.85                  

Exercised

    (17   $ 1.30                  

Forfeited or expired

    (12   $ 11.69                  
   

 

 

                         

Outstanding at September 30, 2012

    1,397     $ 9.95       5.9     $ 1,361 (1)  
   

 

 

   

 

 

   

 

 

   

 

 

 

Exercisable at September 30, 2012

    967     $ 9.71       4.4     $ 1,341 (1)  
   

 

 

   

 

 

   

 

 

   

 

 

 

 

(1)

The intrinsic value is the amount by which the market price of our stock was greater than the exercise price of any individual option grant at September 30, 2012.